Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 2591 · · 10 pages · English
Summary by 6ix AI
It confirms the total authorised and registered share capital at the end of the month. The report also includes information on issued shares and public float sufficiency confirmation. The filing indicates that there were no changes in the number of issued shares during the month.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Guangzhou Innogen Pharmaceutical Group Co Ltd on 6ix
Earlier from Guangzhou Innogen Pharmaceutical
- Interim Report 2026
- Innogen Pharmaceuticals Receives PIC/S GMP Certificatation, Accelerating Global Expansion of Efsubaglutide Alfa
- Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions
Later from Guangzhou Innogen Pharmaceutical
- (1) Resignation of directors; and (2) change in composition of strategy committee
- List of directors and their roles and functions
- Voluntary announcement - appointment of senior management
Follow Guangzhou Innogen Pharmaceutical into a list and get an email when it puts out news.
Follow Guangzhou Innogen Pharmaceutical